Dr
Vishal
Chander
Dr
Vishal
Chander
Scientist
Indian Veterinary Research Institute
Biography
Dr Vishal Chander is working as a research Scientist in the Indian Council of Agricultural Research (ICAR) since the year 2009 and posted at ICAR- Indian Veterinary Research Institute, Bareilly and then Mukteshwar Campus since 2022. He has qualified my doctoral degree in Veterinary Microbiology (Immunology) and have a good expertise on investigation and diagnosis of the diseases of livestock, companion and wild animals. He has more than 14 years of research experience on diagnosis, epidemiology, monitoring and surveillance of animal diseases. Presently, he is working on diagnostics and vaccine of canine parvovirus, canine coronoavirus and infectious canine hepatitis. He has more than 40 research papers published in the journals of national and international repute. The PI has the experience of developing Canine parvovirus vaccine candidate CPV 2a of Indian origin in his PhD research and thus preliminary work of demonstration of proof of concept (PoC) in animals, the Provisional Application, Indian Patent Application No.: 202111015216 have been filed for the same.
The PI has different canine viral isolates of CAV 2 (Chander, 2021; Genbank Acc no. MT318141) and CAV 1 (Genbank Acc no. KX181846, MT880782, MT895850; Chetan et al., 2019) which would be helpful in carrying out the immunogenicity and serum neutralisation studies. CAV 1 has also been identified in the wild animals also.
Research interests
My interests are in Innate and adaptive immunity against viral infectious disease of animals. Vaccine development for canine viral diseases as CPV and ICH including indigenous strains. Diagnostic tests against animal viral diseases including molecular and pen side tests. Discipline
Immunology – B-cells Virology Host species
Buffalo Camels Cats Cattle Dogs Horses Pigs Poultry Small ruminants Wildlife Zoonoses Pathogen
Viruses Viruses›African swine fever virus Viruses›Influenza virus Viruses›Parvovirus Viruses›Poxviruses Viruses›Rabies virus Stage of vaccine development
Clinical trials Correlates of protection – immunomonitoring Field trials Pre-clinical trials Vaccine delivery